SOURCE: Horizon Pharma plc

Horizon Pharma plc

May 14, 2015 07:00 ET

Horizon Pharma plc Announces That Amy Grahn Honored as a 2015 Healthcare Businesswomen's Association Luminary

DUBLIN, IRELAND--(Marketwired - May 14, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that Amy Grahn, senior vice president, global clinical development, operations and pharmacovigilance, has been named a 2015 Healthcare Businesswomen's Association (HBA) Luminary. Amy will be honored today at the 26th annual Woman of the Year event in New York.

The HBA is the leading not-for-profit global organization committed to further the advancement and impact of women in healthcare worldwide. Amy was recognized for her dedication to advancing other women's careers throughout her more than 20-year career in the pharmaceutical industry.

"I'm honored to receive such an important award and be recognized alongside other women leaders who are shaping the healthcare industry," said Amy Grahn, senior vice president, global clinical development, operations and pharmacovigilance, Horizon Pharma plc. "I share this award with colleagues who have guided me during the course of my career and with those who I have mentored along the way."

Amy joined Horizon Pharma in January 2009 as vice president, global clinical development and operations and was promoted to senior vice president in 2010 with additional responsibility for pharmacovigilance added in 2014. She has more than two decades of pharmaceutical industry experience spanning pre-clinical research to commercial roles, with a primary focus on clinical operations. Prior to joining Horizon Pharma, Amy served as vice president of clinical operations at MedGenesis Therapeutix Inc. in British Columbia, Canada, where she was responsible for strategic planning, development and implementation of clinical and pre-clinical development plans for therapeutic agents delivered via the MedGenesis convection-enhanced delivery (CED) platform.

"Amy is extremely deserving of this award based on not only her individual business contributions, but her ability to foster successful career growth for her colleagues," said Timothy P. Walbert, chairman, president and chief executive officer, Horizon Pharma plc.

About Horizon Pharma plc
Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The company markets seven medicines through its orphan, primary care and specialty business units. Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com.

About the Healthcare Businesswomen's Association (HBA)
The Healthcare Businesswomen's Association (HBA) is a global not-for-profit organization dedicated to furthering the advancement and impact of women in healthcare worldwide. With 15 chapters throughout the US and in Europe, HBA serves a community of over 30,000 individuals and 100 Corporate Partners. The HBA provides networking forums to build relationships; knowledge sharing and access to thought leaders to broaden perspective; educational programs to develop leadership skills and cutting edge industry knowledge and recognition of outstanding women and companies to promote visibility of their achievements.

Contact Information

  • Contacts:

    Investors:
    John Thomas
    Executive Vice President, Strategy and Investor Relations
    Email Contact

    U.S. Media:
    Geoff Curtis
    Group Vice President, Corporate Communications
    Email Contact